PANACEA BIOTEC
Quarterly Results Analysis [Sep2024]
PANACEA BIOTEC Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 Audited |
Mar2023 UnAudited |
Dec2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹116 Cr | ₹136 Cr | ₹151 Cr | ₹143 Cr | ₹129 Cr | ₹129 Cr | ₹115 Cr | ₹105 Cr |
Expenses | ₹130 Cr | ₹143 Cr | ₹151 Cr | ₹147 Cr | ₹140 Cr | ₹135 Cr | ₹124 Cr | ₹109 Cr |
Operating Income | ₹-14 Cr | ₹-6 Cr | ₹0 Cr | ₹-4 Cr | ₹-10 Cr | ₹-6 Cr | ₹-9 Cr | ₹-4 Cr |
Other Income | ₹4 Cr | ₹11 Cr | ₹6 Cr | ₹3 Cr | ₹6 Cr | ₹15 Cr | ₹14 Cr | ₹10 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Profit Before Tax | ₹-17 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr | ₹13 Cr | ₹18 Cr | ₹22 Cr | ₹23 Cr |
Profit After Tax | ₹-16 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr | ₹11 Cr | ₹-13 Cr | ₹19 Cr | ₹16 Cr |
EPS | ₹-2.58 | ₹-0.23 | ₹-0.36 | ₹-1.35 | ₹1.78 | ₹-2.02 | ₹3.16 | ₹2.56 |
Industry Peers & Returns | 1W | 1M | 1Y |
PANACEA BIOTEC | -7.8% | 8.1% | 169.5% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
CIPLA | 1.7% | 0.5% | 23.7% |
DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
LUPIN | 4.1% | 5.1% | 71.7% |
PANACEA BIOTEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -15.20 % |
Y-o-Y | -10.43 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹116 Cr | -15.20 | |
Jun2024 | ₹136 Cr | -9.33 | |
Mar2024 | ₹151 Cr | 5.23 | |
Dec2023 | ₹143 Cr | 10.71 | |
Sep2023 | ₹129 Cr | 0.20 | |
Jun2023 | ₹129 Cr | 11.92 | |
Mar2023 | ₹115 Cr | 9.59 | |
Dec2022 | ₹105 Cr | - |
PANACEA BIOTEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹-14 Cr | Negative | |
Jun2024 | ₹-6 Cr | Negative | |
Mar2024 | ₹0 Cr | Negative | |
Dec2023 | ₹-4 Cr | Negative | |
Sep2023 | ₹-10 Cr | Negative | |
Jun2023 | ₹-6 Cr | Negative | |
Mar2023 | ₹-9 Cr | Negative | |
Dec2022 | ₹-4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | -12.09% | Negative | |
Jun2024 | -4.43% | Negative | |
Mar2024 | -0.1% | Negative | |
Dec2023 | -2.49% | Negative | |
Sep2023 | -7.98% | Negative | |
Jun2023 | -4.4% | Negative | |
Mar2023 | -7.5% | Negative | |
Dec2022 | -3.65% | - |
PANACEA BIOTEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹-16 Cr | Negative | |
Jun2024 | ₹-2 Cr | Negative | |
Mar2024 | ₹-2 Cr | Negative | |
Dec2023 | ₹-8 Cr | Negative | |
Sep2023 | ₹11 Cr | Positive | |
Jun2023 | ₹-13 Cr | Negative | |
Mar2023 | ₹19 Cr | 23.38 | |
Dec2022 | ₹16 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | -13.72 % | Negative | |
Jun2024 | -1.46 % | Negative | |
Mar2024 | -1.46 % | Negative | |
Dec2023 | -5.8 % | Negative | |
Sep2023 | 8.5 % | Positive | |
Jun2023 | -9.83 % | Negative | |
Mar2023 | 16.81 % | 12.52 | |
Dec2022 | 14.94 % | - |
PANACEA BIOTEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹-2.58 | Negative | |
Jun2024 | ₹-0.23 | Negative | |
Mar2024 | ₹-0.36 | Negative | |
Dec2023 | ₹-1.35 | Negative | |
Sep2023 | ₹1.78 | Positive | |
Jun2023 | ₹-2.02 | Negative | |
Mar2023 | ₹3.16 | 23.44 | |
Dec2022 | ₹2.56 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD